$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"
쳇봇 이모티콘
안녕하세요!
ScienceON 챗봇입니다.
궁금한 것은 저에게 물어봐주세요.

논문 상세정보

한국 소아 B형 간염의 역학과 현황

The epidemiology and present status of chronic hepatitis B in Korean children

Korean journal of pediatrics v.51 no.7 , 2008년, pp.696 - 703  
Abstract

Korea is now classified as an area of intermediate endemicity for hepatitis B virus (HBV), due to the implementation of universal HBV vaccination and national preventive programs for HBV infection. A national program of HBV vaccination was launched in Korea in 1988 for school-going children and was listed on a vaccination guideline in 1991. In 1995, universal vaccination for newborn infants was started for the prevention of perinatal HBV transmission. The prevalence of HBsAg among Korean middle school students has shown marked decreased from 3.2% in the late 1990s to 0.44% in 2007. HBsAg positivity in preschool children was 0.9% in 1995, decreased to 0.2% in 2007 by national prevention program of hepatitis B vertical transmission, launched in 2002. Vaccine failure rate of HBV immunoprophylaxis is 4.2% by this program. The infected children should be monitored per 6-12 months interval. Lamivudine and interferon are approved therapies for children with chronic hepatitis B in immune-clearance phase in Korea.

저자의 다른 논문

참고문헌 (42)

  1. Lee DH, Kim JH, Nam JJ, Kim HR, Shin HR. Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea. J Korean Med Sci 2002;17:457-62 
  2. The Third Korea National Health and Nutrition Examination Survey (KNHANES III), 2005 - Health Examination-. In: Korean Centers for Disease Control and Prevention 2006: 68-209 
  3. Communicable diseases surveillance yearbook. In: Korean Centers for Disease Control and Prevention; 2005:suppl.1-5 
  4. Jang MK, Lee JY, Lee JH, Kim YB, Kim HY, Yoo JY. The investigation for the change of HBsAg positive rate of grade junior high high-schoolers for recent 3 years in Kangwon province. Korean J Med 2000;58:608-15 
  5. Current state of survey of national immunity. In: Korean Centers for Disease Control and Prevention / Research team for epidemiology; 2008 
  6. Choe BH. Hepatitis B vaccine: prevention of perinatal infection and management of nonresponder. Korean J Pediatr Gastroenterol Nutr 2007;10:91-100 
  7. Choe BH. The management and treatment of chronic hepatitis B in Korean children. Korean J Pediatr 2007;50:823-34 
  8. 2006 Report of the Korean Centers for Disease Control and Prevention In: Korean Centers for Disease Control and Prevention 2006:144-8 
  9. 2006 Report of the Korean centers for disease control and prevention In: Korean Centers for Disease Control and Prevention 2006:292-6 
  10. 2008 Guidebook of Hepatitis B vertical transmission prevention program. In: Ministry for Health, Welfare and Family Affairs/Korean Centers for Disease Control and Prevention 2008:6-16 
  11. Kong H, Kim JH, Cho NY, Kim YH, lung KM, Yeon JE, et al. The hepatitis B carrier rate in siblings of patients with HBV -associated chronic liver disease. Korean J Hepatol 2001;7:387-91 
  12. Choe BH, Kim JO, Kim YM, Lee JH. Therapeutic efficacy of adefovir in children with chronic hepatitis B with lamivudine resistance. Program and Abstract, the 57th Annual Fall Meeting of the Korean Pediatric Society; 2007 Oct. 19-20; Seoul; 2007. p. 233 
  13. 2005 Report of the Korean centers for disease control and prevention In: Korean Centers for Disease Control and Prevention 2005:147-51 
  14. Kim B, Seo K, Park S, Kim Y, Park O, Lee H, et al. Evaluation of prevention program for neonatal vertical transmission from HBsAg positive mother in Korea. Korean J Obstet Gynecol 2005;48:2067-72 
  15. Choe BH, Kim JM, Lee JH, Jang YC, Jang CH, Oh KW, et al. Lamivudine treatment in children with chronic hepatitis B: long-term therapeutic response, optimal duration and resistance. Program and Abstract, the 39th Annual Meeting of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition; 2006; Dresden, Germany; 2006. p. 47 
  16. Chun BY, Lee MK, Rho YK. The prevalence of hepatitis B surface antigen among Korean by literature review. Korean J Epidemiol 1992;14:70-8 
  17. Annual statistical report of causes of death. In: Korea National Statistical Office 2004 
  18. Choe BH. Hepatitis B virus: pathogenesis, molecular diagnosis, and clinical significance of mutation. Korean J Pediatr Gastroenterol Nutr 2007;10:51-65 
  19. Lee SY, Choi BY, Shin YJ, Bang KN, Ki M, Park HB, et al. seroepidemiological study on hepatitis B vaccination program-in elemantary school student from Kyonggi-do province. Korean J Pediatr Infectious Dis 1997;4:240-56 
  20. Kim RK SI, Nam HM, Han KH. The incidence of hepatitis B in military service and the effect of asymptomatic HBsAg carriers on the incidence. Korean J Prev Med 1997;30:267-78 
  21. Epidemiological investigation on infectious diseases in Korea-annual report 2006. In: Ministry for Health, Welfare and Family Affairs/Korean Centers for Disease Control and Prevention; 2006 
  22. 2004 Report of the Korean centers for disease control and prevention In: Korean Centers for Disease Control and Prevention 2004:365-7 
  23. Choe BH, Lee JH, jang YC, Jang CH, Oh KW, Kwon S, et al. Long-term therapeutic efficacy of lamivudine compared to interferon-alpha in children with chronic hepatitis B: the younger the better. J Pediatr Gastroenterol Nutr 2007:44:92-8 
  24. Choe BH, Tak WY, Kweon YO. Predictors of therapeutic response and resistance by long-term follow-up in lamivudine treated children and adolescence with chronic hepatitis B. Program and Abstract, the lSth conference of the Asian Pacific Association for the Study of the Liver 200S; Seoul: Hepatology International; 200S. p. 220 
  25. Huh K, Choi SY, Whang YS, Lee DS. Prevalence of viral hepatitis markers in Korean patients with hepatocellular carcinoma. J Korean Med Sci 1998;13:306-10 
  26. Korea National Health and Nutrition Examination Survey. In: Ministry for Health, Welfare and Family Affairs 2001 
  27. Ministry of Education, Science, Technology. 2006 Report of the sampling analysis results of students' health examination. In: Yonhap News 2007:9-20 
  28. Sokal EM, Jonas MM, Kelley DA. Safety, efficacy and pharmacokinetics of adefovir dipivoxil in children and adolescents with chronic hepatitis B. Program and Abstract, the 40th Annual meeting of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition; 2007; Barcelona, Spain; 2007. p. abstract 4 
  29. Choe YH, Seo JK, Yun JH, Lee HS. Recent changes in prevalence of hepatitis B viral markers in preschool children in Seoul, 1995. J Korean Pediatr Soc 1996;39:1254-9 
  30. 2005 Report of the Korean Centers for Disease Control and Prevention In: Korean Centers for Disease Control and Prevention 2005:295-7 
  31. Kim JM, Choe BH. HBsAg loss by lamivudine treatment in children with chronic hepatitis B. Program and Abstract, the 14th Annual meeting of the Korean Association for the Study of the Liver, 2008 May 17; Daegu: Korean J Hepatol 2008;14:s36 
  32. Kim RK, Ahn BM, Lee DS, Lee KM, Park YM, Lee YS, et al. Changes in the positivities of HBsAg and anti-HCV antibody among army draftees in Korea. Korean J Hepatol 2000;6:474-80 
  33. Sim JG, Seo JK, Suh SJ. Prevalence and its changes of hepatitis B viral markers from 1988 to 1993 in Korean children. J Korean Pediatr Soc 1995;38:1535-9 
  34. 2007 KASL chronic hepatitis B treatment guideline. In: The Korean Association for the Study of the Liver 2007:5-56 
  35. KCDCP. Hepatitis B vertical transmission prevention program. In: Communicable Diseases Monthly Report, CDMR 2008:14 
  36. Health Behavior and Chronic Disease Statistics. In: Korean Centers for Disease Control and Prevention / Research team for chronic diseases 2006:114-9 
  37. Communicable diseases surveillance yearbook. In: Korean Centers for Disease Control and Prevention 2006:400-3 
  38. The Third Korea National Health and Nutrition Examination Survey (KNHANES III), Further investigation reportHealth Examination -. In: Korean Centers for Disease Control and Prevention 2007:194-204 
  39. Jang MK, Lee JY, Lee JH, Kim YB, Kim HY, Lee MS, et al. Seroepidemiology of HBV infection in South Korea, 1995 through 1999. KoreanJ Intern Med 2001;16:153-9 
  40. Broderick AL, Jonas MM. Hepatitis B in children. Semin Liver Dis 2003;23:59-68 
  41. Wang JS, Zhu QR, Wang XH. Breastfeeding does not pose any additional risk of immunoprophylaxis failure on infants of HEV carrier mothers. Int J Clin Pract 2003;57:100-2 
  42. Evaluation study for the efficacy improval of vaccination program based on the goal establishment of national vaccination project. In: Council of Vaccination, Korean Centers for Disease Control and Prevention 1997:62 

이 논문을 인용한 문헌 (0)

  1. 이 논문을 인용한 문헌 없음

원문보기

원문 PDF 다운로드

  • ScienceON :

원문 URL 링크

원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다. (원문복사서비스 안내 바로 가기)

상세조회 0건 원문조회 0건

DOI 인용 스타일